Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichiro Tohi

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|July 20, 2022
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter studyYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 25, 2025
Needlestick Injury During Urological Surgery: A 15-Year Review From a Multi-Institutional Study in the Chugoku-Shikoku Japan Urological ConsortiumYutaro Sasaki, Satoshi Katayama, Yoichiro Tohi, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological ConsortiumHideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Temporal changes in the urologist's practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Akira Yokomizo, Ryuji Matsumoto, et al.
BJU International|June 18, 2024
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 13, 2026
Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic TherapyNaoki Akagi, Akihiko Nagoshi, Masashi Kubota, et al.
International Journal of Clinical Oncology|December 6, 2022
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN studyYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
Prostate Cancer and Prostatic Diseases|July 13, 2021
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPANTakuma Kato, Hiromi Hirama, Koji Mitsuzuka, et al.
Japanese Journal of Clinical Oncology|October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortiumSatoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Urology : Official Journal of the Japanese Urological Association|July 20, 2022
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter studyYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 25, 2025
Needlestick Injury During Urological Surgery: A 15-Year Review From a Multi-Institutional Study in the Chugoku-Shikoku Japan Urological ConsortiumYutaro Sasaki, Satoshi Katayama, Yoichiro Tohi, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological ConsortiumHideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Temporal changes in the urologist's practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Akira Yokomizo, Ryuji Matsumoto, et al.
BJU International|June 18, 2024
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 13, 2026
Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic TherapyNaoki Akagi, Akihiko Nagoshi, Masashi Kubota, et al.
International Journal of Clinical Oncology|December 6, 2022
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN studyYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
Prostate Cancer and Prostatic Diseases|July 13, 2021
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPANTakuma Kato, Hiromi Hirama, Koji Mitsuzuka, et al.
Japanese Journal of Clinical Oncology|October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortiumSatoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
Pageof 9